EDGAR Filing Documents for 0001398344-24-009031

Form N-CSRS - Certified Shareholder Report, Semi-Annual:

SEC Accession No. 0001398344-24-009031

Filing Date

2024-05-08

Accepted

2024-05-08 17:26:29

Documents

Period of Report

2024-02-29

Effectiveness Date

2024-05-08

Document Format Files

Seq	Description	Document	Type	Size
1		fp0087604-3_ncsrs.htm	N-CSRS	396847
2		fp0087604-3_ex99cert.htm	EX-99.CERT	28863
3		fp0087604-3_ex99906cert.htm	EX-99.906 CERT	5148
4	GRAPHIC	fp0087604-1_i.jpg	GRAPHIC	22400
	Complete submission text file	0001398344-24-009031.txt		463228

Series and Classes/Contracts Information:

Existing
	Status	Name	Ticker Symbol
CIK 0001540305
Series S000050740		Range Cancer Therapeutics ETF
Class/Contract C000160229		Range Cancer Therapeutics ETF	CNCR

Mailing Address 615 EAST MICHIGAN ST MILWAUKEE WI 53202

Business Address 615 EAST MICHIGAN ST MILWAUKEE WI 53202 414-287-3700

ETF Series Solutions (Filer) CIK: 0001540305 (see all company filings)